Rossari Biotech share price

Balanced risk
  • 35%Low risk
  • 35%Moderate risk
  • 35%Balanced risk
  • 35%High risk
  • 35%Extreme risk
  • 685.80(-0.25%)
    April 17, 2025 15:29:43 PM IST
    • NSE
    • BSE
  • Vol : 27.64K (NSE + BSE)
    Last 20 day avg : 85.47 K

Rossari Biotech is trading -0.25% lower at Rs 685.80 as compared to its last closing price. Rossari Biotech has been trading in the price range of 688.60 & 677.00. Rossari Biotech has given -12.38% in this year & 6.80% in the last 5 days. Rossari Biotech has TTM P/E ratio 31.57 as compared to the sector P/E of 17.95.There are 5 analysts who have initiated coverage on Rossari Biotech. There are 4 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 31.70 Crores in its last quarter.Listed peers of Rossari Biotech include Grauer & Weil (india) (1.79%), Nacl Industries (5.00%), Rossari Biotech (-0.25%).The Mutual Fund holding in Rossari Biotech was at 13.25% in 31 Dec 2024. The MF holding has increased from the last quarter. The FII holding in Rossari Biotech was at 3.74% in 31 Dec 2024. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Apr 19, 2025, 02:01 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.07
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    3.59
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    27.72
    Lower than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.11
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.11
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
677.00
Highest
688.60
52 week range
Lowest
568.05
Highest
966.00
Rossari Biotech Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in December quarter by 10.56% from Rs 512.73 crore to Rs 463.77 crore, year-on-year
    • financial-insightsThe company's profit declined by 7.82% year-on-year during the December quarter, dropping from Rs 34.39 crore to Rs 31.70 crore
    • financial-insightsThe debt to equity of the company is lower than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Rossari Biotech Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 671.35
  • R2
  • 738.65
  • R3
  • 780.30
Pivot629.70
  • S1
  • 562.40
  • S2
  • 520.75
  • S3
  • 453.45
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Rossari Biotech Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Grauer & Weil (india)
Moderately Bearish
85.821.793,891.1826.624.830.580.68
Nacl Industries
Bullish
190.205.003,793.33-7.39-29.23
Rossari Biotech
Neutral
685.80-0.253,796.8529.143.590.074.22
Bhagiradha Chemicals & Industri
Moderately Bearish
284.55-0.943,689.73177.227.160.044.15
Kiri Industries
Bullish
641.80-0.133,570.2725.011.18-0.85
Rossari Biotech Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Rossari Biotech is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 68.19%
    • InsightsPromoter(s) have decreased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding is constant over the last quarter at 3.74%
    • InsightsMutual Funds holding has increased by 0.07 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    Motilal Oswal Small Cap Fund Regular Growth
    NA
    • Amount Invested (Cr.) 66.49
    • % of AUM 1.60
    SBI Infrastructure Fund Regular Growth
    3/5
    • Amount Invested (Cr.) 54.42
    • % of AUM 1.16
    Canara Robeco Small Cap Fund Regular Growth
    2/5
    • Amount Invested (Cr.) 64.54
    • % of AUM 0.58
    UTI Small Cap Fund Regular Growth
    2/5
    • Amount Invested (Cr.) 19.32
    • % of AUM 0.47
    UTI Flexi Cap Fund Regular Plan Growth
    2/5
    • Amount Invested (Cr.) 107.76
    • % of AUM 0.44
    Rossari Biotech Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-01-21Quarterly Results
    2024-10-19Quarterly Results
    2024-07-20Quarterly Results
    2024-04-29Audited Results & Final Dividend
    2024-01-20Quarterly Results
    About the company Rossari Biotech
    • IndustryChemical Manufacturing
    • ISININE02A801020
    • BSE Code543213
    • NSE CodeROSSARI
    Rossari Biotech Limited is an India-based company. The Company is engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumer centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. It operates through three segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC), and Animal Health and Nutrition (AHN). HPPC produces acrylic polymers, manufacturing a sustainable range of products for various applications in the cleaning industry. TSC is focused on providing customers with eco-friendly, sustainable chemical solutions. It provides solutions for pre-treatment, dyeing and printing, finishing, and specialty chemicals for the entire value chain of the textile industry. AHN provides wellness solutions for pet animals and poultry, focusing on their health and performance.
    • Management Info
    • Edward MenezesExecutive Chairman of the Board, Co-Founder
    • Sunil ChariManaging Director, Co-Founder, Executive Director
    • Ketan SablokGroup Chief Financial Officer
    • Parul GuptaCompliance Officer, Company Secretary
    Rossari Biotech Share Price FAQs

    Rossari Biotech is trading at 685.80 as on Thu Apr 17 2025 09:59:43. This is -0.25% lower as compared to its previous closing price of 687.55.

    The market capitalization of Rossari Biotech is 3796.85 Cr as on Thu Apr 17 2025 09:59:43.

    The average broker rating on Rossari Biotech is Strong Buy. The breakup of analyst rating is given below -

    • 4 analysts have given a strong buy rating
    • 0.00 analysts have given a buy rating
    • 1 analysts have given a hold rating
    • 0.00 analysts have given a sell rating
    • 0.00 analysts have given a strong sell rating

    The 52 wk high for Rossari Biotech is 966.00 whereas the 52 wk low is 568.05

    Rossari Biotech can be analyzed on the following key metrics -

    • TTM P/E: 31.57
    • Sector P/E: 17.95
    • Dividend Yield: 0.07%
    • D/E ratio: -

    Rossari Biotech reported a net profit of 130.69 Cr in 2024.

    The Mutual Fund Shareholding was 13.25% at the end of 31 Dec 2024.